“…Thus, novel neuromodulation approaches targeting sympathetic nerve inhibition might be potential for the treatment of resistant hypertension. Tremendous evidences have proved that neuromodulation techniques such as functional electrical stimulation (FES) of the carotid baroreceptor (Scheffers et al, 2010;Bisognano et al, 2011;Lohmeier and Iliescu, 2011;Bakris et al, 2012;Hoppe et al, 2012)/vagus nerve (Plachta et al, 2014;Gierthmuehlen et al, 2016;Annoni et al, 2019) and renal sympathetic denervation (RSD) by different devices and techniques [including surgical sympathectomy (Smithwick, 1948), laparoscopic sympathectomy (Gao et al, 2019), catheterbased radiofrequency ablation (Krum et al, 2009), endovascular ultrasound (Fengler et al, 2019), injection of neurotoxic agents (Lohmeier and Hall, 2019), external stereotactic radiofrequency (Cai et al, 2019), external high-intensity focused ultrasound (Wang et al, 2013), etc.,] might reduce BP through sympathetic nerve activity inhibition. However, these procedures of current neuromodulation methods are either invasive or associated with complete nerve damage.…”